Strategy Driven

JUNE 22, 2020

When countries impose strong lockdown curfews on their citizens, only businesses deemed “essential” are allowed to operate as normal. Technology is another necessity in today’s modern world. Pharmaceuticals. One sector to consider that is both unaffected by COVID-19 and economic recessions is the pharmaceutical industry.

Pharmaceuticals 65

Pharmaceuticals Insurance Industry Transportation 65

The Horizons Tracker

FEBRUARY 22, 2022

That we’re still largely waiting for such an immersive world to take hold, despite much-hyped initiatives, such as Second Life, perhaps underlines the difficulties the technology has had in keeping pace with such a vision. Digital twins. It’s a market that is already worth $3.1

Stephenson 114

Stephenson Wireless Christensen Automotive 114

Strategy Driven

DECEMBER 18, 2020

Financial Technology Will Be in Higher Demand. As more businesses move to virtual formats, the need for financial technology will continue to increase in 2021. Gayhardt states that Hong Kong is already increasing its use of advanced fraud detection, biometric facial recognition, and other innovative AI technologies due to the pandemic.

Retail 77

Retail Supply Chain Pharmaceuticals Technology 77

The Horizons Tracker

OCTOBER 9, 2019

Countries around the world have made a concerted effort to try and encourage more young people to take an interest in science, technology, engineering and maths (STEM), with an understandable belief that these topics are vital for the competitive edge of a modern economy.

Pharmaceuticals 74

Pharmaceuticals Education ROI Project 74

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. The researchers highlight the particular impact on businesses in the travel and hospitality sectors, who have all suffered due to the lockdown measures. Face-to-face interactions.

Pharmaceuticals 58

Pharmaceuticals Transportation Retail Long-term 58

The Horizons Tracker

NOVEMBER 3, 2024

So, when we’re operating in a more remote or hybrid environment, the strength of our social ties is crucial if we want teams to function well. Moving around The researchers used a pharmaceutical company to conduct their experiment, with the company relocating their regional offices in Singapore and Kuala Lumpur respectively.

Pharmaceuticals 72

Pharmaceuticals Long-term Bond Cooper 72

Strategy Driven

JULY 13, 2011

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Some examples include new technologies, changes in customer preferences, new ways of serving customers, and disruptive threats. One dimension of this is the needed flows of talent.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

MARCH 18, 2011

Large downturns (such as this recession), technology disruptions, or regulatory shifts create discontinuities that simply accelerate the industry’s evolution toward this equilibrium state. Companies today operate in a business environment that encourages incoherence. The leading companies are getting out in front of this trend.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 15

COO Sample Telecommunications Automotive 15

Harvard Business Review

MAY 16, 2011

The Sun-Netscape Alliance was formed when AOL acquired Netscape in 1998 but then sought to spin out the software operations of Netscape. At the end of the three years, all operations reverted to Sun and the "collaboration" ended, leaving but a trace of itself in Sun's product line.

Software 18

Software Licensing Long-term Telecommunications 18

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 14

Pharmaceuticals Banking Chemicals Entrepreneur 14

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. So where is the link to health care?

Health Care 17

Health Care Retail Operations Insurance 17

Harvard Business Review

OCTOBER 26, 2011

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 15

Energy Finance IPO Biotechnology 15

Harvard Business Review

FEBRUARY 22, 2011

Everyone" includes primary care doctors, medical specialists, nurses, hospital administrators, health insurance providers, nutritionists, pharmaceutical companies, medical technology manufacturers, fitness gurus, paraprofessionals, public health commissioners, and charities dedicated to a disease.

Health Care 16

Health Care Innovation Pharmaceuticals Consensus 16

Harvard Business Review

JULY 8, 2016

China has not been a huge technology innovator, despite being the world’s second-largest investor in R&D , but Chinese businesses have found ways to use innovations in processes, business models, and customer experience to their disruptive advantage.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Perhaps profits are rising because firms are increasingly making profitable investments in new technology, in IT, or in their organizational capabilities. Profits are up. Corporate valuations are up as well. But is it good news for society?

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 16

Apparel Pharmaceuticals Finance Licensing 16

Harvard Business Review

AUGUST 14, 2018

The term “digital firms” refers to those companies that from their inception have focused on digital services enabled by the internet and related technologies, including mobile. imposing technological platforms developed for the U.S. failure to fully embed operations in China. market on China.

Competitive Advantage 14

Competitive Advantage Business Model Technology Marketing 14

Harvard Business Review

JULY 12, 2011

Long term commitment in a world where the technology is advancing almost on a daily basis is difficult to maintain. Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. Judge McVeigh's punch line applies across a range of industries.

Management 15

Management Airlines How To Pharmaceuticals 15

Harvard Business Review

SEPTEMBER 21, 2018

Fewer than one-third (30%) of respondents to our survey see innovation as one of the top three challenges their company faces in achieving its strategic objectives, and just 21% think that technology trends are a major strategic challenge. These firms also had higher-rated processes for innovation. Director Recruitment and Skills.

Innovation 14

Innovation Short-term Telecommunications Long-term 14

Harvard Business Review

NOVEMBER 15, 2018

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. Cost reduction requires an honest and thorough reassessment of everything the health system does and ultimately, a change in the organization’s operating culture. PM Images/Getty Images. ” Clearly, more is needed.

Cost 14

Cost System Management Franchising 14

Harvard Business Review

MARCH 2, 2011

McKinsey teams are beavering away in places like the United Arab Emirates and the 'Stans — Turkmenistan, say, or Tajikistan — but they're as likely to be doing operations projects as pure strategy work. The most intense competition between consulting firms is for "whale" engagements.

Consultative 16

Consultative Strategy McKinsey Porter 16

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. The technology world has some harrowing examples that no innovation-based industry should ever forget. billion tender offer directly to shareholders.

Innovation 15

Innovation Company Biotechnology CFO 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. To best leverage worldwide creative talent, Reliance MediaWorks operates a global network of creative centers located in Burbank, San Francisco, London, Tokyo, and across India. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 14

Globalization Innovation Decentralization Chemicals 14

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. At the same time, the marketplace has become so fiercely competitive—and investors so demanding—that few are willing to take a flyer on an unproven technology. Dr. Mukesh V.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Information & technology Operations Organizational culture Product development'

Products 10

Products Productivity Company Engineering 10

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

NOVEMBER 1, 2017

While the in-person DPPs were largely successful in reducing disease risk and incidence, Duffy and James recognized that there was substantial opportunity to better scale the DPP and make it more accessible and personalized by using technology.

Health Care 19

Health Care Participative Wireless Pharmaceuticals 19

Harvard Business Review

JUNE 22, 2016

But all assets are not created equal, especially as the technological landscape changes. Even when these firms rely on physical assets, like cars for Uber, they own the technology, not the physical asset. Digital native upstarts are gutting traditional industries one at a time, leveraging scalable technology and participative networks.

Intangible Assets 13

Intangible Assets Business Model How To Intellectual Capital 13

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

JANUARY 31, 2013

Increasingly, customers demand more after-sale service; this is the norm now in business-to-business sales, but will spill over to consumer goods, too, thanks to some of the technology advances we'll talk about below. All over the world, automakers are mastering new drive train technologies.

Globalization 12

Globalization Supply Chain Pharmaceuticals McKinsey 12

Harvard Business Review

JANUARY 8, 2013

arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). He emailed Christopher Tan, a marketer with an interest in mobile technologies and experience building applications, and within 36 hours, they had come up with a prototype. But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 12

Company Pharmaceuticals Health Care Participative 12

Harvard Business Review

SEPTEMBER 20, 2011

economy as a whole, rather than the narrow, specific slices of technology or communication, the first decade of the 21st century did not generate expected growth in jobs, revenues, profits, or stock prices. The business press puts a tremendous focus on technology and innovation, but what it doesn't do is put it into context.

Innovation 15

Innovation Supply Chain Offshoring Policies 15

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. While a natural inclination, this group is (by design) representative of current operating units and functions, which often have a status quo to defend. paul Garbett for HBR.

Leadership 14

Leadership Diversity Committee Long-term 14